GPCR Inhibitor (Rewind Therapeutics)

N/A

Report date: 2025/01/26 16:22:34
NME

Base Information

Drug NameGPCR Inhibitor (Rewind Therapeutics)
Drug Alias NameG Protein-coupled Receptor Inhibitor (Rewind Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor antagonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsHereditary Central Nervous System Demyelinating Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRewind Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesRewind Therapeutics
Inactive CompaniesN/A
Active IndicationsHereditary Central Nervous System Demyelinating Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A